Effects of O‐1602 and CBD on TNBS‐induced colonic disturbances

@article{Wei2019EffectsOO,
  title={Effects of O‐1602 and CBD on TNBS‐induced colonic disturbances},
  author={DanDan Wei and HuiChao Wang and JingNan Yang and ZhiFeng Dai and Ruilin Yang and ShuangShuang Meng and YongYu Li and Xuhong Lin},
  journal={Neurogastroenterology \& Motility},
  year={2019},
  volume={32}
}
This study attempted to provide the effects and mechanisms of two cannabinoids, O‐1602 and cannabidiol (CBD), on colonic motility of 2,4,6‐trinitro‐benzene sulfonic acid (TNBS) colitis. 

References

SHOWING 1-10 OF 46 REFERENCES
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents
  • X. Lin, B. Yuece, +6 authors M. Storr
  • Biology, Medicine
  • Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • 2011
Differential effects of CB1 neutral antagonists and inverse agonists on gastrointestinal motility in mice
  • M. Storr, M. Bashashati, +8 authors K. Sharkey
  • Biology, Medicine
  • Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
  • 2010
The endogenous cannabinoid system protects against colonic inflammation.
...
1
2
3
4
5
...